The Biotech Acceleration of 2026: Record Deals, AI-Designed Genomes, Nobel Prizes, and the New Biosecurity Map
From record M&A and billion-dollar AI drug discovery rounds to in-body prime editing, AI-designed phage genomes, two life-science Nobel Prizes and new U.S. DNA screening rules, here is what mattered in biotech from mid-May to …
